Kymera Therapeutics Inc. (KYMR)
NASDAQ: KYMR
· Real-Time Price · USD
42.62
1.07 (2.58%)
At close: Aug 15, 2025, 3:59 PM
43.44
1.92%
After-hours: Aug 15, 2025, 05:03 PM EDT
Kymera Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 335.82M | 89.97M | 120.26M | 110.72M | 67.61M | 93.51M | 109.97M | 81.05M | 52.39M | 50.15M | 68.39M | 155.66M | 76.91M | 33.73M | 47.98M | 156.82M | 84.9M | 53.1M |
Short-Term Investments | 329.63M | 373.18M | 368.49M | 439.25M | 442.34M | 427.03M | 264.92M | 276.77M | 315.19M | 346.73M | 338.77M | 326.25M | 315.39M | 387.08M | 394.44M | 379.57M | 274.2M | 280.44M |
Long-Term Investments | 303.45M | 312.33M | 362.16M | 361.04M | 198.29M | 230.22M | 61.43M | 76.99M | 104.76M | 119.02M | 152.33M | 113.7M | 90.18M | 102.48M | 125.19M | 74.69M | 45.3M | 101.64M |
Other Long-Term Assets | 4.67M | 9.12M | 7.74M | 5.78M | 1.89M | 2.12M | 7.93M | 8.6M | 8.6M | -95.04M | -122.02M | 9.13M | 8.54M | 8.13M | -98.77M | 2.31M | 2.51M | 1.62M |
Receivables | 40M | 20M | 947K | 1.32M | 1.7M | 2.03M | 18.76M | 3.78M | 4.12M | 3.32M | 2.54M | 2.88M | 2.37M | 1.26M | 135K | 1.57M | 904K | 1.73M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -14.67M | -12.25M | n/a | n/a | n/a | -8.86M | n/a | n/a | n/a |
Other Current Assets | 22.88M | 17.8M | 20.58M | 17.43M | 13.75M | 14.68M | 11.67M | 14.09M | 13.71M | 11.35M | 9.71M | 9.23M | 8.09M | n/a | 8.72M | 5.77M | n/a | n/a |
Total Current Assets | 728.33M | 500.95M | 510.27M | 568.72M | 525.41M | 537.25M | 405.32M | 375.69M | 385.4M | 515.89M | 559.49M | 494.02M | 402.77M | 431.38M | 567.61M | 543.73M | 364.81M | 340.79M |
Property-Plant & Equipment | 94.62M | 95.91M | 97.86M | 99.31M | 100.44M | 98.67M | 101.08M | 91.1M | 83.18M | 74.04M | 13.33M | 21.62M | 21.93M | 21.07M | 11.88M | 21.72M | 21.77M | 20.5M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 402.74M | 417.36M | 467.77M | 466.13M | 300.61M | 331M | 170.44M | 176.68M | 196.54M | 98.01M | 43.64M | 144.45M | 120.65M | 131.68M | 38.3M | 98.72M | 69.58M | 123.76M |
Total Assets | 1.13B | 918.31M | 978.03M | 1.03B | 826.02M | 868.25M | 575.76M | 552.38M | 581.95M | 613.9M | 603.13M | 638.47M | 523.42M | 563.06M | 605.9M | 642.45M | 434.39M | 464.55M |
Account Payables | 5.78M | 10.26M | 5.99M | 6.49M | 6.51M | 6.81M | 7.08M | 4.98M | 3.75M | 6.48M | 4.33M | 6.33M | 2.37M | 2.57M | 4M | 5.03M | 8.18M | 8.35M |
Deferred Revenue | 40M | 11.48M | 13.58M | 20.02M | 19.26M | 22.61M | 37.88M | 27.35M | 24.3M | 57.11M | 63.26M | 55.78M | 59.46M | 60.85M | 101.03M | 66.23M | 82.26M | 87.91M |
Short-Term Debt | 13.67M | n/a | n/a | n/a | 12.42M | n/a | 6.34M | 3.6M | 3.8M | n/a | n/a | 3.62M | 3.66M | 3.57M | n/a | 3.63M | 3.46M | 3.05M |
Other Current Liabilities | 20.64M | 893K | 223K | 17.63M | 5.4M | 12.25M | 16.82M | 15.59M | 14.01M | 15.72M | 303K | 3.25M | 361K | 15.5M | 17.17M | 12.1M | 9M | 6.51M |
Total Current Liabilities | 87.54M | 58.99M | 67.77M | 66.53M | 62.14M | 56.14M | 85.69M | 63.17M | 54.6M | 123.54M | 63.26M | 91.12M | 87.5M | 88.34M | 101.03M | 94.49M | 108.69M | 110.14M |
Long-Term Debt | 72.05M | n/a | n/a | n/a | 75.77M | n/a | 78.33M | 77.25M | 71.26M | 64.86M | n/a | 13.12M | 13.63M | 13.9M | n/a | 14.81M | 14.84M | 14.42M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | -75.77M | n/a | -78.33M | -77.24M | -71.03M | -64.63M | 248K | -12.87M | -13.37M | -13.63M | 66K | -14.73M | -14.76M | -14.33M |
Total Long-Term Liabilities | 72.05M | 73.09M | 74.65M | 75.38M | 78.95M | 100.91M | 95.1M | 93.68M | 91.92M | 28.36M | 49.72M | 34.46M | 37.97M | 46M | 45.23M | 64.83M | 67.6M | 79.17M |
Total Liabilities | 159.59M | 132.08M | 142.42M | 141.91M | 141.1M | 157.05M | 180.79M | 156.84M | 146.52M | 151.9M | 112.98M | 125.59M | 125.47M | 134.34M | 146.27M | 159.32M | 176.28M | 189.31M |
Total Debt | 85.71M | 86.33M | 87.76M | 88.23M | 88.18M | 87.02M | 84.67M | 80.84M | 75.06M | 66.43M | 17.34M | 16.74M | 17.29M | 17.47M | 17.96M | 18.44M | 18.3M | 17.47M |
Common Stock | 7K | 7K | 7K | 7K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 5K | 5K | 5K | 5K | 5K | 4K |
Retained Earnings | -896.8M | -820.19M | -754.61M | -683.86M | -621.37M | -579.31M | -530.75M | -516.38M | -463.52M | -424.72M | -383.79M | -348.93M | -305.92M | -265.67M | -228.98M | -195.08M | -166.5M | -141.84M |
Comprehensive Income | 279K | -58K | -1.49M | 1.93M | -2.1M | -1.78M | -552K | -2.45M | -3.63M | -3.04M | -4.95M | -5.91M | -3.98M | -3.22M | -660K | -146K | n/a | -13K |
Shareholders Equity | 971.48M | 786.23M | 835.62M | 892.93M | 684.92M | 711.2M | 394.97M | 395.54M | 435.43M | 462M | 490.15M | 512.88M | 397.95M | 428.72M | 459.64M | 483.13M | 258.1M | 275.25M |
Total Investments | 633.08M | 685.52M | 730.65M | 800.29M | 640.63M | 657.25M | 326.35M | 276.77M | 315.19M | 346.73M | 491.1M | 439.95M | 405.58M | 489.56M | 519.63M | 454.26M | 319.51M | 382.08M |